sb 203580 has been researched along with nabumetone in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (nabumetone) | Trials (nabumetone) | Recent Studies (post-2010) (nabumetone) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 393 | 105 | 60 |
| Protein | Taxonomy | sb 203580 (IC50) | nabumetone (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 5 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.868 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.998 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.868 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramson, SB; Apsel, B; Chan, ES; Chang, LF; Clancy, R; Dinsell, V; Gomez, P; Marjanovic, N; Pillinger, MH; Tolani, SN | 1 |
1 other study(ies) available for sb 203580 and nabumetone
| Article | Year |
|---|---|
Regulation of metalloproteinases and NF-kappaB activation in rabbit synovial fibroblasts via E prostaglandins and Erk: contrasting effects of nabumetone and 6MNA.
Topics: Alprostadil; Analysis of Variance; Animals; Butadienes; Butanones; Cell Line; Cell Survival; Cyclooxygenase Inhibitors; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Imidazoles; Interleukin-1; Matrix Metalloproteinase 1; Metalloendopeptidases; Nabumetone; Naphthaleneacetic Acids; NF-kappa B; Nitric Oxide; Nitriles; Phosphorylation; Prostaglandins E; Pyridines; Rabbits; Synovial Membrane; Tumor Necrosis Factor-alpha | 2004 |